N-(2-(3-HYDROXY-3-METHYLBUTYL)-6-(2-HYDROXYPROPAN-2-YL)INDAZOL-5-YL)-2-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1,3-OXAZOLE-4-CARBOXAMIDE
UNII Z2Q52AR5MQ
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(2-(3-hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl)-2-(2-(trifluoromethyl)pyridin-4-yl)-1,3-oxazole-4-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z2Q52AR5MQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2944466-66-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H26F3N5O4 RMBPIJMVJCMBQZ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(2-(3-hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl)-2-(2-(trifluoromethyl)pyridin-4-yl)-1,3-oxazole-4-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.